Management of Agitation, Confusion, and Distress in a 93-Year-Old Woman with Multi-Infarct Dementia
A comprehensive approach combining non-pharmacological interventions and careful medication management is recommended for this 93-year-old woman with moderate multi-infarct dementia experiencing agitation, confusion, and distress, with citalopram dosage requiring careful evaluation and possible adjustment.
Initial Assessment and Non-Pharmacological Approaches
- Perform a thorough assessment of potential causes for the patient's agitation, confusion, and distress, including evaluation for pain, discomfort, infections, dehydration, fecal impaction, and adverse medication effects 1
- Describe and quantify verbal, nonverbal, and physical behavioral symptoms to better understand patterns and triggers 1
- Assess for environmental, situational, social, and psychological factors that may be contributing to her distress 1
- Implement an interdisciplinary approach involving the patient's family and retirement home staff to develop individualized care plans 1
Non-Pharmacological Interventions (First-Line)
- Provide meaningful activities tailored to the patient's past roles, interests, and current abilities 1, 2
- Increase social engagement through structured activities appropriate for her cognitive level 1
- Improve communication techniques with the patient:
- Establish predictable daily routines that promote safety and well-being 1
- Address loneliness and social isolation through appropriate social support programs 1
- Consider environmental modifications to create a more homelike atmosphere with familiar objects 1
Medication Management
Current Citalopram Treatment
- Evaluate the current dose of citalopram, which should not exceed 20 mg/day in patients over 60 years due to risk of QT prolongation 3
- Monitor for potential adverse effects of citalopram, including:
Medication Adjustments
- Consider reducing citalopram to 20 mg daily if currently at a higher dose, as this lower dose may still be effective for agitation while minimizing cardiac and cognitive risks 5, 3
- SSRIs like citalopram are considered first-line pharmacological treatments for agitation in dementia when medication is necessary 2, 6
- In the CitAD trial, citalopram showed significant improvement in agitation compared to placebo but with concerns about QT prolongation and cognitive effects at 30 mg daily 4
- Avoid adding antipsychotics if possible, as they pose significant safety risks including increased mortality in elderly patients with dementia 7
- Make periodic attempts (every 6 months) to taper or discontinue medication for dementia-related behavioral symptoms 1
Ongoing Monitoring and Follow-up
- Regularly reassess the effectiveness of both non-pharmacological and pharmacological interventions 1
- Monitor vital signs, cognitive function, and cardiac status (particularly QTc interval) 3
- Evaluate for any new medical conditions or medication side effects that could be contributing to behavioral symptoms 1
- Involve the daughter in care planning and provide education about dementia behaviors not being intentional 1
- Consider a trial of dose reduction after 3-6 months if symptoms have significantly improved 7
Addressing Specific Concerns
- For the patient's desire to leave the facility:
Caregiver Support and Education
- Educate the daughter about the link between dementia and behavioral symptoms 1
- Emphasize that behaviors are not intentional but manifestations of the disease 1
- Provide strategies for effective communication and managing difficult situations 1
- Connect the daughter with support resources to manage caregiver stress 1
Common Pitfalls to Avoid
- Avoid excessive reliance on medications without addressing underlying causes of distress 1, 2
- Do not dismiss the patient's expressions of wanting to leave as merely symptoms; they may indicate legitimate unmet needs 1
- Avoid confrontational approaches or complex explanations that may increase agitation 1
- Do not overlook the importance of regular medication review and attempts at dose reduction 1
- Avoid using physical restraints or unnecessary psychotropic medications to manage wandering behaviors 1